China National Medicines Corp Ltd
SSE:600511
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Goldcrest Co Ltd
TSE:8871
|
JP |
China National Medicines Corp Ltd
Goodwill
China National Medicines Corp Ltd
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Goodwill
¥203.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
59%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Goodwill
¥12.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
1%
|
CAGR 10-Years
10%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Goodwill
¥806m
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
26%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Goodwill
¥2.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
15%
|
CAGR 10-Years
71%
|
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Goodwill
¥1.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
37%
|
|
China National Medicines Corp Ltd
Glance View
China National Medicines Corp Ltd., often known as Sinopharm Group's public face, is a leviathan in the realm of pharmaceutical distribution. Headquartered in Beijing, this company is deeply entrenched in the layers of China's healthcare system. Its operations are woven through a vast network that includes the wholesale and retail distribution of an extensive range of pharmaceutical products. The company prides itself on streamlining the supply chain, connecting pharmaceutical manufacturers directly with hospitals, clinics, and pharmacies. By leveraging its logistical expertise and expansive reach, Sinopharm ensures that essential medicines flow seamlessly from producers to end-users, maintaining the vital heartbeat of the healthcare industry across China. In addition to its core distribution business, China National Medicines Corp Ltd. delves into the realm of medical device distribution and other healthcare-related services, diversifying its revenue streams. A significant portion of its income comes from partnerships and agreements with international pharmaceutical behemoths, allowing it to import and distribute advanced medicines and technology within China. By capitalizing on these strategic alliances, the company not only bolsters its portfolio but also strengthens its market position. This symbiotic relationship with both domestic and global players underpins its financial performance, making China National Medicines not just a distributor but a pivotal gatekeeper in the evolving landscape of China's healthcare industry.
See Also
What is China National Medicines Corp Ltd's Goodwill?
Goodwill
203.8m
CNY
Based on the financial report for Sep 30, 2025, China National Medicines Corp Ltd's Goodwill amounts to 203.8m CNY.
What is China National Medicines Corp Ltd's Goodwill growth rate?
Goodwill CAGR 10Y
59%
Over the last year, the Goodwill growth was 0%.